Laboratório de Esquistossomose do Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz , Belo Horizonte , Brazil ; Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais (INCT-DT), Conselho Nacional de Desenvolvimento Científico e Tecnológico, Ministério de Ciência Tecnologia e Inovação, Universidade Federal de Minas Gerais , Belo Horizonte , Brazil.
Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais (INCT-DT), Conselho Nacional de Desenvolvimento Científico e Tecnológico, Ministério de Ciência Tecnologia e Inovação, Universidade Federal de Minas Gerais , Belo Horizonte , Brazil ; Departamento de Bioquímica e Imunologia do Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais , Belo Horizonte , Brazil.
Front Immunol. 2015 Mar 9;6:95. doi: 10.3389/fimmu.2015.00095. eCollection 2015.
The successful development of vaccines depends on the knowledge of the immunological mechanisms associated with the elimination of the pathogen. In the case of schistosomes, its complex life cycle and the mechanisms developed to evade host immune system, turns the development of a vaccine against the disease into a very difficult task. Identifying the immunological effector mechanisms involved in parasite attrition and the major targets for its response is a key step to formulate an effective vaccine. Recent studies have described some promising antigens to compose a subunit vaccine and have pointed to some immune factors that play a role in parasite elimination. Here, we review the immune components and effector mechanisms associated with the protective immunity induced by those vaccine candidates and the lessons we have learned from the studies of the acquired resistance to infection in humans. We will also discuss the immune factors that correlate with protection and therefore could help to evaluate those vaccine formulations in clinical trials.
疫苗的成功开发取决于对与病原体消除相关的免疫机制的了解。就血吸虫而言,其复杂的生命周期和逃避宿主免疫系统的机制使得开发针对该疾病的疫苗成为一项非常困难的任务。鉴定参与寄生虫衰减的免疫效应机制和其反应的主要靶标是制定有效疫苗的关键步骤。最近的研究已经描述了一些有前途的抗原来组成亚单位疫苗,并指出了一些在寄生虫消除中起作用的免疫因素。在这里,我们综述了与那些疫苗候选物诱导的保护性免疫相关的免疫成分和效应机制,以及我们从人类获得性抗感染研究中吸取的经验教训。我们还将讨论与保护相关的免疫因素,因此可以帮助评估临床试验中的这些疫苗配方。